Ci Investments Inc. Repligen Corp Transaction History

Ci Investments Inc.

$25.4 Billion
Q2 2024

A detailed history of Ci Investments Inc. transactions in Repligen Corp stock. As of the latest transaction made, Ci Investments Inc. holds 1,330 shares of RGEN stock, worth $194,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,330

Previous 1,438 7.51%

Holding current value

$194,086

Previous $264,000 36.36%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$120.0 - $182.95 $12,960 - $19,758	-108 Reduced 7.51%	1,330 $168,000
Q1 2024 May 13, 2024	BUY	$170.78 - $208.42 $108,957 - $132,971	638 Added 79.75%	1,438 $264,000
Q4 2023 Feb 12, 2024	SELL	$114.17 - $185.35 $15,869 - $25,763	-139 Reduced 14.8%	800 $144,000
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $19,429 - $24,711	-140 Reduced 12.97%	939 $149,000
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $82,083 - $106,923	593 Added 122.02%	1,079 $153,000
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $62,321 - $80,032	404 Added 492.68%	486 $82,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $481 - $768	3 Added 3.8%	82 $15,000
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $25,603 - $34,219	-182 Reduced 69.73%	79 $13,000
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $2,256 - $3,611	-14 Reduced 5.09%	261 $49,000
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $523,157 - $643,345	-2,113 Reduced 88.48%	275 $73,000
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $465,110 - $774,213	2,388 New	2,388 $690,000
Q3 2020 Nov 09, 2020	SELL	$122.51 - $158.27 $259,843 - $335,690	-2,121 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$94.33 - $140.48 $200,073 - $297,958	2,121 New	2,121 $262,000

Others Institutions Holding RGEN

# of Institutions

495

Shares Held

53.9M

Call Options Held

420K

Put Options Held

85.3K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.1B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Repligen Corp Transaction History